Amgen is investing $600 million to construct a new state-of-the-art research and development facility at its Thousand Oaks headquarters. This expansion will house hundreds of scientists focused on accelerating next-generation drug discovery, featuring advanced automation and digital technologies. The initiative reflects Amgen’s commitment to strengthening US biotech innovation infrastructure amid favorable tax incentives and rising industry investment.